Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurosurgery|February 28, 2023
Cerebral Microbleeds-Long-Term Outcome After Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure HydrocephalusWilliam Hansson, Elias Johansson, Richard Birgander, et al.
Journal of Neurology|August 27, 2013
Diffusion tensor imaging and correlations to Parkinson rating scalesNiklas Lenfeldt, William Hansson, Anne Larsson, et al.
Neurology|July 6, 2012
Three-day CSF drainage barely reduces ventricular size in normal pressure hydrocephalusNiklas Lenfeldt, William Hansson, Anne Larsson, et al.
BMJ Neurology Open|March 17, 2025
Higher-level gait disorders: a population-based study on prevalence, quality of life, depression and confidence in gait and balanceJenny Larsson, William Hansson, Hanna Israelsson Larsen, et al.
Computers in Biology and Medicine|November 30, 2024
An optimized ensemble search approach for classification of higher-level gait disorder using brain magnetic resonance imagesKlara Mogensen, Valerio Guarrasi, Jenny Larsson, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 5, 2024
Cerebral arterial stiffness is linked to white matter hyperintensities and perivascular spaces in older adults - A 4D flow MRI studyCecilia Björnfot, Anders Eklund, Jenny Larsson, et al.
Fluids and Barriers of the CNS|June 13, 2026
Slow unsteady gait in a population-based cohort: links to ventriculomegaly and INPH-related imaging markersJenny Lander, William Hansson, Sanna A Eklund, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Pageof 1